Supportive: resuscitation, fluids, nutrition, vitamin K 10 mg IV for coagulopathy, pruritus control (cholestyramine 4 g up to three times daily), early referral to a hepatobiliary unit.
Pharmacological
- Infected bile or cholangitis: piperacillin-tazobactam 4.5 g IV every 6 to 8 hours or ceftriaxone 2 g IV daily plus metronidazole 500 mg IV every 8 hours; continue 5 to 7 days after drainage.
- Biloma or leak with sepsis: broad spectrum antibiotics plus percutaneous drainage.
- Post-transplant ischaemic biliary lesions: ursodeoxycholic acid 15 mg/kg/day.
Procedures
- Bile leak: endoscopic sphincterotomy with a biliary stent (10 Fr plastic stent for 4 to 8 weeks) bridges leaks; percutaneous drainage of collections; surgical lavage and drainage for bile peritonitis.
- Intraoperative recognition: immediate repair by an experienced hepatobiliary surgeon (duct-to-duct anastomosis over a T-tube for minor lateral injury; Roux-en-Y hepaticojejunostomy for transection or loss of tissue).
- Late stricture (more than 6 weeks): endoscopic balloon dilation with multiple plastic stents or a fully covered metal stent for 12 months (success 70 to 90 percent in anastomotic strictures after transplant, about 60 to 80 percent for cholecystectomy injury).
- Percutaneous transhepatic balloon dilation and drainage for failure or inaccessible anatomy; surgical Roux-en-Y hepaticojejunostomy (long term success 80 to 90 percent) for complete obstruction, high strictures, failed endoscopic therapy, or associated vascular injury.
- Retransplant for end stage biliary cirrhosis or non-anastomotic strictures with graft loss.
Special groups: liver transplant recipients (early hepatic artery Doppler, cytomegalovirus screening), pregnancy (conservative drainage, defer reconstruction), elderly (stenting and drainage rather than major surgery).
Prevention: critical view of safety during cholecystectomy, bail out options (subtotal cholecystectomy, fundus-first technique, cholangiography), avoid indiscriminate thermal energy near the hepatoduodenal ligament.
Red flags: persistent bile drainage, fever with rigors, rising bilirubin, hepatic artery thrombosis, signs of peritonitis, hypotension.
Follow-up: liver profile every 3 months; cholangiography or MRCP at stent removal; annual review for 5 years to detect restenosis and secondary biliary cirrhosis.